Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintaining Optimal Delivery Using Automatic Titration of Oxygen in Preterm Infants Receiving High Velocity Nasal Insufflation Therapy

NCT05030012 is registered in ClinicalTrials.gov with Vapotherm, Inc. as lead sponsor.

NCT NCT05030012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05030012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintaining Optimal Delivery Using Automatic Titration of Oxygen in Preterm Infants Receiving High Velocity Nasal Insufflation Therapy
Lead sponsor
Vapotherm, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
September 2, 2021
Completion date
October 19, 2023
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, infant, premature, neonatal respiratory distress, oxygen saturation